Guangdong Hengrui Pharmaceutical Co., Ltd
5 clinical trials · 5 recruiting · INDUSTRY
Trials by Guangdong Hengrui Pharmaceutical Co., Ltd
RECRUITINGPhase 2 / Phase 3NCT05979051
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis...
This study is a phase 2/3 clinical trial to evaluate the efficacy and safety of SHR-1703 in patients with EGPA.
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 1662 locations
Eosinophilic Granulomatosis With Polyangiitis
RECRUITINGPhase 3NCT06653322
A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in...
The purpose of this study is to evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients with Eosinophil Phenotype
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 4001 location
Asthma With Eosinophilic Phenotype
RECRUITINGPhase 3NCT07098403
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
This study is a phase III study of SHR-1905 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of SHR-1905 in subjects with...
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 4081 location
Asthma
RECRUITINGPhase 2NCT07192939
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of...
To evaluate the efficacy and safety of HRS-9813 in subjects with pulmonary fibrosis。
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 2701 location
IPF and PPF
RECRUITINGPhase 1NCT06821464
A Trial of HRS-9813 in Healthy Subjects
The study is being conducted to evaluate the safety and pharmacokinetics of HRS-9813 after multiple oral administration in healthy subjects.
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 601 location
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis